Moonshots with Peter Diamandis

David Sinclair on the Longevity Pill, Age Reversal Timelines, and Updated Protocols | EP #250

27 Apr 2026

Audio

Description

This episode was filmed at the 2026 Abundance360 Summit. Learn more at https://www.abundance360.com/ In this insightful interview, Dr. David Sinclair discusses groundbreaking advancements in longevity research, including epigenetic reprogramming trials, the potential for extending human lifespan, and accessible therapies. He shares his personal protocols and the future of anti-aging science, emphasizing the importance of innovation and community support. Get access to metatrends 10+ years before anyone else - https://qr.diamandis.com/metatrends David A. Sinclair, A.O., Ph.D., is a tenured Professor of Genetics at Harvard Medical School and a serial biotech entrepreneur. Peter H. Diamandis, MD, is the Founder of XPRIZE, Singularity University, ZeroG, and A360 – My companies: Apply to Dave's and my new fund:https://qr.diamandis.com/linkventureslanding Go to Blitzy to book a free demo and start building today: https://qr.diamandis.com/blitzy Your body is incredibly good at hiding disease. Schedule a call with Fountain Life to add healthy decades to your life, and to learn more about their Memberships: https://www.fountainlife.com/peter _ Connect with Peter: X Instagram Connect with David X Instagram Website Listen to MOONSHOTS: Apple YouTube – *Recorded on March 9th, 2026 *The views expressed by me and all guests are personal opinions and do not constitute Financial, Medical, or Legal advice. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes

🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Other episodes from Moonshots with Peter Diamandis

Transcribed and ready to explore now

David Sinclair: The GLP-1 Side Effect No One Talks About, What AI Found in His Lab, and Reversing Blindness | Q&A EP #251

28 Apr 2026

Moonshots with Peter Diamandis

Elon Musk vs. Sam Altman, AI Job Loss, and OpenAI’s $852B Valuation | EP #247

14 Apr 2026

Moonshots with Peter Diamandis

View all episodes from Moonshots with Peter Diamandis

Comments

There are no comments yet.

Please log in to write the first comment.

Report any issue

Moonshots with Peter Diamandis

David Sinclair on the Longevity Pill, Age Reversal Timelines, and Updated Protocols | EP #250

This episode hasn't been transcribed yet

Other episodes from Moonshots with Peter Diamandis

David Sinclair: The GLP-1 Side Effect No One Talks About, What AI Found in His Lab, and Reversing Blindness | Q&A EP #251

Elon Musk vs. Sam Altman, AI Job Loss, and OpenAI’s $852B Valuation | EP #247

Sign in to Audioscrape

Share this moment